Skip to content

Laryngeal Mask Airway Combined With Lung Collapse for One-Lung Ventration in Tubeless VATS Anesthesia: A Single-Center, Prospective, Three-Arm, Randomized Controlled Clinical Study

Laryngeal Mask Airway Combined With Lung Collapse for One-Lung Ventration in Tubeless VATS Anesthesia: A Single-Center, Prospective, Three-Arm, Randomized Controlled Clinical Study - Laryngeal Mask Airway for One-Lung Ventilation in Tubeless VATS: A Three-Arm Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121605
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wedge resection / segmentectomy / lobectomy of the lung, bullectomy

Interventions

Group D (DLT Group): Double-lumen endotracheal intubation + nerve block + one-lung ventilation under controlled respiration:After induction, insert a double-lumen tube and maintain respiratory control
Group S (LMA-SP Group): Visual laryngeal mask + nerve block + spontaneous respiration preservation (no muscle relaxant or only used during induction):Intraoperatively, lung collapse is facilitated by
Group O (LMA-OLV Group): Visual laryngeal mask + nerve block + one-lung ventilation under controlled respiration after lung collapse:After the establishment of artificial pneumothorax and sufficient c

Sponsors

The First People's Hospital of Guangyuan City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years, ASA III class, BMI 18-30 kg/m²; 2.Planned elective single-port or single-incision VATS surgery (pulmonary wedge/segment/lobectomy, pulmonary bullae resection); 3. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.High risk of difficult airway or regurgitation and aspiration; 2.Severe respiratory insufficiency (resting hypoxemia or hypercapnia); 3.Severe cardiovascular disease (NYHA Class III–IV); 4.Coagulation dysfunction; 5.Anticipated extensive pleural adhesions or massive pleural effusion; 6.Mental or communication disorders; 7.Considered inappropriate by the investigator.

Design outcomes

Primary

MeasureTime frame
Postoperative complications;

Secondary

MeasureTime frame
Ventilation and oxygenation indicators;

Countries

China

Contacts

Public ContactZhangli

The First People's Hospital of Guangyuan City

1092869815@qq.com+86 187 8122 9899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026